Publications and communications of Erik Maquoi

Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Chain, J. L., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (2023). Poly(N-methyl‐N‐vinylacetamide): a strong alternative to PEG for lipid‐based nanocarriers delivering siRNA. Advanced Healthcare Materials, 2302712. doi:10.1002/adhm.202302712

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (27 April 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticle tracking method [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (21 March 2023). Impact of the hydrophobic chain length of PEG derivatives on the behavior of LNPs in serum: Development of a Nanoparticle Tracking Analysis (NTA) Method [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (01 February 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticles tracking method [Paper presentation]. CIRM Day, Liege, Belgium.

Ledoux, A., Hamann, C., Bonnet, O., Jullien, K., Quetin-Leclercq, J., Tchinda, A., Smadja, J., Gauvin-Bialecki, A., Maquoi, E., & Frederich, M. (25 January 2023). Bioactive Clerodane Diterpenoids from the Leaves of Casearia coriacea Vent. Molecules, 28 (3), 1197. doi:10.3390/molecules28031197

Gommes, C., Louis, T., Bourgot, I., Blacher, S., Noël, A., & Maquoi, E. (2023). Remodelling of the fibre-aggregate structure of collagen gels by cancer-associated fibroblasts: a time-resolved grey-tone image analysis based on stochastic modelling. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.988502

Hamann, C., Jansen, O., Desdemoustier, P., Ledoux, A., Maquoi, E., & Frederich, M. (28 August 2022). Characterization of the type of interaction between terpenoids and cannabinoids compounds of hemp plant against MDA-MB-231 cancer-cells by isobologram analyses [Poster presentation]. 70th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA), Thessalonique, Greece.

PAYE, A., Truong, A., Yip, C., Cimino, J., Blacher, S., Munaut, C., Cataldo, D., Foidart, J. M., Maquoi, E., Collignon, J., Delvenne, P., Jerusalem, G., Noël, A., & Sounni, N. E. (15 February 2022). Editor's Note: EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP. Cancer Research, 82 (4), 734. doi:10.1158/0008-5472.CAN-21-4292

Hamann, C., Jansen, O., Desdemoustier, P., Marotte, A., Bonnet, O., Maquoi, E., & Frederich, M. (02 February 2022). Preliminary study of the phytochemical composition and biological activity of 5 varieties of hemp cultivated in Wallonia [Poster presentation]. CIRMDay2022.

Saby, C., Maquoi, E., Saltel, F., & Morjani, H. (22 December 2021). Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell Phenotype. Frontiers in Cell and Developmental Biology, 9. doi:10.3389/fcell.2021.808625

Ledoux, A., Bériot, D., Coelho Cristino Mamede, L. C., Desdemoustier, P., Detroz, F., Jansen, O., Frederich, M., & Maquoi, E. (2021). Cytotoxicity of Poupartone B, an Alkyl Cyclohexenone Derivative from Poupartia borbonica, against Human Cancer Cell Lines. Planta Medica. doi:10.1055/a-1532-2384

Gallez, A., Blacher, S., Maquoi, E., Konradowski, E., Joiret, M., Primac, I., Gérard, C., Taziaux, M., Houtman, R., Geris, L., Lenfant, F., Marangoni, E., Sounni, N. E., Foidart, J.-M., Noël, A., & Pequeux, C. (2021). Estetrol combined to progestogen for menopause or contraception indication is neutral on breast cancer. Cancers. doi:10.3390/cancers13102486

Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006

Bourgot, I.* , Primac, I.* , Louis, T., Noël, A., & Maquoi, E. (18 August 2020). Reciprocal Interplay Between Fibrillar Collagens and Collagen-Binding Integrins: Implications in Cancer Progression and Metastasis. Frontiers in Oncology, 10 (1488). doi:10.3389/fonc.2020.01488

Saby, C., Collin, G., Sinane, M., Buache, E., VAN GULICK, L., Saltel, F., Maquoi, E., & Morjani, H. (June 2020). DDR1 and MT1-MMP expression are determinant for triggering BIK-mediated apoptosis by 3D type I collagen matrix in invasive basal-like breast carcinoma cells [Poster presentation]. AACR Meeting, United States.

Azarkan, M., Maquoi, E., Delbrassine, F., Herman, R., M'Rabet, N., Calvo-Esposito, R., Charlier, P., & Kerff, F. (2020). Structures of the free and inhibitors-bound forms of bromelain and ananain from Ananas comosus stem and in vitro study of their cytotoxicity. Scientific Reports. doi:10.1038/s41598-020-76172-5

Bourgot, I., Louis, T., Kasabova, M., Blacher, S., Reinheckel, T., Noël, A., & Maquoi, E. (20 September 2019). Impact of cancer associated fibroblasts-derived cathepsin B on breast cancer progression [Poster presentation]. Mechanobiology of Cancer Summer School 2019, La Cerdanya, Spain.

Bourgot, I., Louis, T., Kasabova, M., Blacher, S., Reinheckel, T., Noël, A., & Maquoi, E. (19 September 2019). Impact of cancer associated fibroblasts-derived cathepsin B on breast cancer progression [Paper presentation]. Mechanobiology of Cancer Summer School 2019, La Cerdanya, Spain.

Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., Cataldo, D., Pihlajaniemi, T., Pequeux, C., De Wever, O., Gullberg, D., & Noël, A. (09 July 2019). Stromal integrin alpha11 regulates PDGFR-beta signaling and promotes breast cancer progression. Journal of Clinical Investigation, 130. doi:10.1172/JCI125890

Jansen, O., Desdemoustier, P., Maquoi, E., Marotte, A., DJIERRO, K., & Hamann, C. (17 May 2019). Screening of 25 Euphorbiaceae for their in vitro cytotoxic activity against two cancer cell lines [Poster presentation]. Phytoday 2019, BRUXELLES, Belgium.

FOIDART, P., Yip, C., Radermacher, J., Blacher, S., Lienard, M., MONTERORUIZ, L., Maquoi, E., Montaudon, E., Chateau-Joubert, S., COLLIGNON, J., Coibion, M., Jossa, V., Marangoni, E., Noël, A., Sounni, N. E.* , & JERUSALEM, G.*. (2019). Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-18-1880

Louis, T., Bourgot, I., Primac, I., Maquoi, E., Blacher, S., & Noël, A. (2019). Novel 3D microscopy techniques and image analysis algorithms to study cancer-related in vitro spheroid models [Poster presentation]. Focus on Microscopy 2019, Londres, United Kingdom.

Saby, C., Collin, G., Sinane, M., Buache, E., Van Gulick, L., Saltel, F., Maquoi, E.* , & Morjani, H.*. (2019). DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells. Frontiers in Pharmacology, 10, 462. doi:10.3389/fphar.2019.00462

Saby, C., Rammal, H., Magnien, K., Buache, E., Brassart-Pasco, S., Van-Gulick, L., Jeannesson, P., Maquoi, E.* , & Morjani, H.*. (2018). Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells. Cell Adhesion and Migration. doi:10.1080/19336918.2018.1472182

Louis, T., Blacher, S., Bourgot, I., Durré, T., Primac, I., Gillot, L., Maquoi, E., & Noël, A. (2018). Novel 3D microscopy techniques and image processing and quantification algorithms to study cancer-related biological models [Poster presentation]. Joint Meeting GIGA-Cancer Day 2018 / EDT-Cancerology, Liège, Belgium.

Assent, D., Bourgot, I., Hennuy, B., Geurts, P., Foidart, J.-M., Noël, A., & Maquoi, E. (October 2016). A membrane-type- matrix metalloproteinase (MT1-MMP) - discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells [Poster presentation]. EACR Meeting - Goodbye flat biology : models, mechanisms and microenvironment, Berlin, Germany.

Saby, C., Rammal, H., Magnien, K., Pasco-Brassart, S., Maquoi, E., Jeannesson, P., & Morjani, H. (October 2016). Regulation of breast carcinoma cell proliferation and apoptosis by type I collagen aging and 3D confinement involves differential activation of DDR1 [Poster presentation]. EACR - GOODBYE FLAT BIOLOGY: MODELS, MECHANISMS AND MICROENVIRONMENT, Berlin, Germany.

Assent, D., Bourgot, I., Hennuy, B., Geurts, P., Noël, A., Foidart, J.-M., & Maquoi, E. (04 March 2016). A Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP)- Discoïdin Domain Receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells [Poster presentation]. International Joint Meeting of the German and French Societies for Matrix Biology, Freiburg, Germany.

Assent, D., Bourgot, I., Hennuy, B., Geurts, P., Noël, A., Foidart, J.-M., & Maquoi, E. (2015). A Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP) - Discoidin Domain Receptor 1 Axis Regulates Collagen-Induced Apoptosis in Breast Cancer Cells. PLoS ONE, 10 (3), 0116006. doi:10.1371/journal.pone.0116006

Paye, A., Truong, A., Yip, C., Cimino, J., Blacher, S., Munaut, C., Cataldo, D., Foidart, J.-M., Maquoi, E., COLLIGNON, J., Delvenne, P., Jerusalem, G., Noël, A.* , & Sounni, N. E.*. (October 2014). EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP. Cancer Research, 74 (23), 6758-70. doi:10.1158/0008-5472.CAN-13-2994

Matheus, N., Hansen, S., Rozet, E., Peixoto, P., Maquoi, E., LAMBERT, V., Noël, A., Frederich, M., Mottet, D., & De Tullio, P. (January 2014). An Easy, Convenient Cell and Tissue Extraction Protocol for Nuclear Magnetic Resonance Metabolomics. Phytochemical Analysis, 25, 342-349. doi:10.1002/pca.2498

Maquoi, E., Assent, D., Foidart, J.-M., & Noël, A. (27 September 2013). Molecular mechanisms of type I collagen-induced apoptosis in breast carcinoma cells [Poster presentation]. 21st ECDO Euroconference on Apoptosis : Cell death, a biomedical paradigm, Paris, France.

Maquoi, E., Assent, D., Detilleux, J., Pequeux, C., Foidart, J.-M., & Noël, A. (26 January 2012). MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis. Oncogene, 31 (4), 480-93. doi:10.1038/onc.2011.249

Noël, A., Gutierrez-Fernandez, A., Sounni, N. E., Behrendt, N., Maquoi, E., Lund, I., Cal, S., Hoyer-Hansen, G., & Lopez-Otin, C. (2012). New and Paradoxical Roles of Matrix Metalloproteinases in the Tumor Microenvironment. Frontiers in Pharmacology, 3 (140), 1. doi:10.3389/fphar.2012.00140

LORQUET, S., Berndt, S., Blacher, S., Gengoux, E., Peulen, O., Maquoi, E., Noël, A., Foidart, J.-M., Munaut, C., & Pequeux, C. (2010). Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB Journal, 24 (10), 3782-95. doi:10.1096/fj.09-149070

Van Steenkiste, M., Oltenfreiter, R., Frankenne, F., Vervoort, L., Maquoi, E., Noël, A., Foidart, J.-M., Van De Wiele, C., & De Vos, F. (2010). Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent. Cancer Biotherapy and Radiopharmaceuticals, 25 (5), 511-20. doi:10.1089/cbr.2010.0789

Noël, A., Jost, M., & Maquoi, E. (2008). Matrix metalloproteinases at cancer tumor-host interface. Seminars in Cell and Developmental Biology, 19, 52-60. doi:10.1016/j.semcdb.2007.05.011

Klein, J., Permana, P. A., Owecki, M., Chaldakov, G. N., Böhm, M., Hausman, G., Lapière, C. M., Atanassova, P., Sowiński, J., Fasshauer, M., Hausman, D. B., Maquoi, E., Tonchev, A. B., Peneva, V. N., Vlachanov, K. P., Fiore, M., Aloe, L., Slominski, A., Reardon, C. L., ... Pond, C. M. (January 2007). What are subcutaneous adipocytes really good for...? Experimental Dermatology, 16 (1), 45-70. doi:10.1111/j.1600-0625.2006.00519_1.x

Chabottaux, V., Sounni, N. E., Pennington, C. J., English, W. R., van den Brule, F., Blacher, S., Gilles, C., Munaut, C., Maquoi, E., Lopez-Otin, C., Murphy, G., Edwards, D. R., Foidart, J.-M., & Noël, A. (15 May 2006). Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Research, 66 (10), 5165-5172. doi:10.1158/0008-5472.CAN-05-3012

Vörös, G., Maquoi, E., Demeulemeester, D., Clerx, N., Collen, D., & Lijnen, R. (October 2005). Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology, 146 (10), 4545-4554. doi:10.1210/en.2005-0532

Maquoi, E., Vörös, G., Carmeliet, P., Collen, D., & Lijnen, R. (May 2005). Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice. Arteriosclerosis, Thrombosis and Vascular Biology, 25 (5), 1002-1007. doi:10.1161/01.ATV.0000160611.68791.c6

Maquoi, E., Sounni, N. E., Devy, L., Olivier, F., Frankenne, F., Krell, H. W., Grams, F., Foidart, J.-M., & Noël, A. (15 June 2004). Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Clinical Cancer Research, 10 (12, Pt 1), 4038-4047. doi:10.1158/1078-0432.CCR-04-0125

Noël, A., Maillard, C., Rocks, N., Jost, M., Chabottaux, V., Sounni, N. E., Maquoi, E., Cataldo, D., & Foidart, J.-M. (June 2004). Membrane associated proteases and their inhibitors in tumour angiogenesis. Journal of Clinical Pathology, 57 (6), 577-584. doi:10.1136/jcp.2003.014472

Sounni, N. E., Roghi, C., Chabottaux, V., Janssen, M., Munaut, C., Maquoi, E., Galvez, B. G., Gilles, C., Frankenne, F., Murphy, G., Foidart, J.-M., & Noël, A. (02 April 2004). Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. Journal of Biological Chemistry, 279 (14), 13564-13574. doi:10.1074/jbc.M307688200

Vörös, G., Maquoi, E., Collen, D., & Lijnen, R. (March 2004). Influence of membrane-bound tumor necrosis factor (TNF)-alpha on obesity and glucose metabolism. Journal of Thrombosis and Haemostasis, 2 (3), 507-513. doi:10.1111/j.1538-7933.2004.00612.x

Maquoi, E., Peyrollier, K., Noël, A., Foidart, J.-M., & Frankenne, F. (01 July 2003). Regulation of membrane-type 1 matrix metalloproteinase activity by vacuolar H+-ATPases. Biochemical Journal, 373 (Pt 1), 19-24. doi:10.1042/BJ20030170

Maquoi, E., Demeulemeester, D., Vörös, G., Collen, D., & Lijnen, R. (April 2003). Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thrombosis and Haemostasis, 89 (4), 696-704. doi:10.1055/s-0037-1613586

Lijnen, R., Demeulemeester, D., Van Hoef, B., Collen, D., & Maquoi, E. (February 2003). Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thrombosis and Haemostasis, 89 (2), 249-255. doi:10.1055/s-0037-1613439

Vörös, G., Maquoi, E., Collen, D., & Lijnen. (03 January 2003). Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories. Biochimica et Biophysica Acta-Gene Structure and Expression, 1625 (1), 36-42. doi:10.1016/S0167-4781(02)00589-4

Lijnen, R., Maquoi, E., Morange, P., Vörös, G., Van Hoef, B., Kopp, F., Collen, D., Juhan-Vague, I., & Alessi, M.-C. (01 January 2003). Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arteriosclerosis, Thrombosis and Vascular Biology, 23 (1), 78-84. doi:10.1161/01.ATV.0000044457.60665.DD

Lijnen, R., Maquoi, E., Demeulemeester, D., Van Hoef, B., & Collen, D. (August 2002). Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thrombosis and Haemostasis, 88 (2), 345-353. doi:10.1055/s-0037-1613208

Maquoi, E., Munaut, C., Colige, A., Collen, D., & Lijnen, R. (April 2002). Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes, 51 (4), 1093-1101. doi:10.2337/diabetes.51.4.1093

Lijnen, R., Maquoi, E., Hansen, L. B., Van Hoef, B., Frederix, L., & Collen, D. (01 March 2002). Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arteriosclerosis, Thrombosis and Vascular Biology, 22 (3), 374-379. doi:10.1161/hq0302.104522

Sounni, N. E., Baramova, E., Munaut, C., Maquoi, E., Frankenne, F., Foidart, J.-M., & Noël, A. (01 March 2002). Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization. International Journal of Cancer, 98 (1), 23-28. doi:10.1002/ijc.10134

Maquoi, E., Munaut, C., Colige, A., Lambert, C., Frankenne, F., Noël, A., Grams, F., Krell, H.-W., & Foidart, J.-M. (2002). Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors. Experimental Cell Research, 275 (1), 110-21. doi:10.1006/excr.2002.5489

Lijnen, R., Maquoi, E., Holvoet, P., Mertens, A., Lupu, F., Morange, P., Alessi, M. C., & Juhan-Vague, I. (June 2001). Adipose tissue expression of gelatinases in mouse models of obesity. Thrombosis and Haemostasis, 85 (6), 1111-1116. doi:10.1055/s-0037-1615971

Noël, A., Albert, V., Bajou, K., Bisson, C., Devy, L., Frankenne, F., Maquoi, E., Masson, V., Sounni, N. E., & Foidart, J.-M. (April 2001). New Functions of Stromal Proteases and Their Inhibitors in Tumor Progression. Surgical Oncology Clinics of North America, 10 (2), 417-32. doi:10.1016/s1055-3207(18)30073-5

GOFFIN, F., Maquoi, E., & Foidart, J.-M. (2001). Placentation et métalloprotéases. In Implantation et placentation. Physiologie, pathologies et traitements. Paris, France: MAsson.

Maquoi, E., Frankenne, F., Noël, A., Krell, H. W., Grams, F., & Foidart, J.-M. (15 December 2000). Type Iv Collagen Induces Matrix Metalloproteinase 2 Activation in Ht1080 Fibrosarcoma Cells. Experimental Cell Research, 261 (2), 348-59. doi:10.1006/excr.2000.5063

Maquoi, E., Frankenne, F., Baramova, E., Munaut, C., Sounni, N. E., Remacle, A., Noël, A., Murphy, G., & Foidart, J.-M. (14 April 2000). Membrane Type 1 Matrix Metalloproteinase-Associated Degradation of Tissue Inhibitor of Metalloproteinase 2 in Human Tumor Cell Lines. Journal of Biological Chemistry, 275 (15), 11368-78. doi:10.1074/jbc.275.15.11368

Maquoi, E., Munaut, C., Colige, A., Lambert, C., Frankenne, F., Noël, A., Grams, F., Krell, H. W., & Foidart, J.-M. (30 June 1999). Paradoxical Stimulation of Matrix Metalloproteinase-9 Expression in Ht1080 Cells by a Broad-Spectrum Hydroxamate-Based Matrix Metalloproteinase Inhibitor. Annals of the New York Academy of Sciences, 878, 744-6. doi:10.1111/j.1749-6632.1999.tb07779.x

Noël, A., Kebers, F., Maquoi, E., & Foidart, J.-M. (1999). Cell-Cell and Cell-Matrix Interactions During Breast Cancer Progression. Current Topics in Pathology. Ergebnisse der Pathologie, 183-193. doi:10.1007/978-3-642-58456-5_19

Noël, A., Hajitou, A., L'Hoir, C., Maquoi, E., Baramova, E., Lewalle, J.-M., Remacle, A., Kebers, F., Brown, P., Calberg-Bacq, C.-M., & Foidart, J.-M. (13 April 1998). Inhibition of Stromal Matrix Metalloproteases: Effects on Breast-Tumor Promotion by Fibroblasts. International Journal of Cancer, 76 (2), 267-73. doi:10.1002/(SICI)1097-0215(19980413)76:2<267::AID-IJC15>3.0.CO;2-9

Maquoi, E., Noël, A., Frankenne, F., Angliker, H., Murphy, G., & Foidart, J.-M. (13 March 1998). Inhibition of Matrix Metalloproteinase 2 Maturation and Ht1080 Invasiveness by a Synthetic Furin Inhibitor. FEBS Letters, 424 (3), 262-6. doi:10.1016/S0014-5793(98)00187-2

Maquoi, E., Polette, M., Nawrocki, B., Bischof, P., Noël, A., Pintiaux, A., Santavicca, M., Schaaps, J.-P., Pijnenborg, R., Birembaut, P., & Foidart, J.-M. (May 1997). Expression of Stromelysin-3 in the Human Placenta and Placental Bed. Placenta, 18 (4), 277-85. doi:10.1016/S0143-4004(97)80062-8

Maquoi, E., Noël, A., & Foidart, J.-M. (1997). Matrix metalloproteinases in choriocarcinoma cell lines: a potential regulatory role of extracellular matrix components. In J.-M. Foidart, J. Aplin, P. Kaufmann, ... J.-P. Schaaps, Placenta. Trophoblast Research. Early Pregnancy (pp. 18, Supplement 2, Pages 123-142). Elsevier.

Maquoi, E., Schaaps, J.-P., Jacobs, J. L., Noël, A., & Foidart, J.-M. (1997). La prééclampsie est la conséquence d'un déficit de placentation: de la biologie aux considérations cliniques. Revue Médicale de Liège, 52 (7), 478-84.

Maquoi, E., van den Brule, F. A., Castronovo, V., & Foidart, J.-M. (1997). Changes in the Distribution Pattern of Galectin-1 and Galectin-3 in Human Placenta Correlates with the Differentiation Pathways of Trophoblasts. Placenta, 18 (5-6, Jul-Aug), 433-9. doi:10.1016/S0143-4004(97)80044-6

Noël, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J. M., Maquoi, E., Munaut, C., Remacle, A., & Foidart, J.-M. (1997). Emerging Roles for Proteinases in Cancer. Invasion and Metastasis, 17 (5), 221-39.

Crescimanno, C., Foidart, J.-M., Noël, A., Polette, M., Maquoi, E., Birembaut, P., Baramova, E. N., Kauffmann, P., & Castellucci, M. (1996). Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A. Experimental Cell Research, 227, 240-251. doi:10.1006/excr.1996.0273

Nawrocki, B., Polette, M. E., Marchand, V., Maquoi, E., Beorchia, A., Tournier, J. M., Foidart, J.-M., & Birembaut, P. (1996). Membrane-type matrix metalloproteinase-1 expression at the site of human placentation. Placenta, 17 (8), 565-72. doi:10.1016/S0143-4004(96)80073-7

Noël, A., Lefebvre, O., Maquoi, E., Vanhoorde, L., Chenard, M. P., Mareel, M., Foidart, J.-M., Basset, P., & Rio, M. C. (1996). Stromelysin-3 expression promotes tumor take in nude mice. Journal of Clinical Investigation, 97, 1924-1930. doi:10.1172/JCI118624

Polette, M., Nawrocki, B., PINTIAUX, A., Massenat, C., Maquoi, E., Volders, L., SCHAAPS, J.-P., Birembaut, P., & Foidart, J.-M. (December 1994). Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Laboratory Investigation, 71 (6), 838-846.